Cited by 125

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease

Alexopoulou, Zoi, Lang, Johannes, Perrett, Rebecca M., Elschami, Myriam, Hurry, Madeleine E. D., Kim, Hyoung Tae, Mazaraki, Dimitra, Szabo, Aron, Kessler, Benedikt M., Goldberg, Alfred Lewis, Ansorge, Olaf, Fulga, Tudor A., Tofaris, George K.·2016·Proceedings of the National Academy of Sciences

Abstract

Significance: A cardinal feature of Parkinson’s disease pathology is the aggregation of α-synuclein in ubiquitin-positive inclusions termed Lewy bodies, yet the composition of ubiquitin conjugates in these inclusions and their role in α-synuclein pathobiology remain unclear. Here we demonstrate that α-synuclein inclusions contain K63-linked ubiquitin chains, which are strikingly reduced in dopaminergic neurons. In these neurons, the deubiquitinase Usp8 is present in Lewy bodies, and its content is related inversely to the extent of K63-linked ubiquitination. Our mechanistic studies in vitro and in flies indicate that Usp8 interacts with and deconjugates K63-linked ubiquitin chains on α-synuclein, prolonging its half-life and increasing its toxicity. Thus, Usp8 appears to be a critical factor determining α-synuclein levels that could be targeted for therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1523597113

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
  2. 10.1038/42166 · DOI · Paper page
  3. 10.1093/brain/aws234 · DOI · Paper page
  4. 10.1002/ana.21380 · DOI
  5. 10.1016/S0169-328X(01)00150-4 · DOI
  6. 10.1016/S0014-5793(01)03115-5 · DOI · Paper page
  7. 10.1073/pnas.1109356108 · DOI · Paper page
  8. 10.1007/BF00687787 · DOI
  9. 10.1002/path.1711550105 · DOI · Paper page
  10. 10.1074/jbc.M308041200 · DOI
  11. 10.1074/jbc.M600933200 · DOI
  12. 10.1016/j.bbamcr.2013.08.012 · DOI
  13. 10.1038/emboj.2012.354 · DOI
  14. 10.1042/BST0340754 · DOI
  15. 10.1091/mbc.e05-06-0560 · DOI · Paper page
  16. 10.1038/emboj.2010.100 · DOI
  17. 10.1038/ng.3166 · DOI
  18. 10.1038/cr.2015.20 · DOI
  19. 10.1016/j.molcel.2009.01.020 · DOI · Paper page
  20. 10.1074/jbc.M704009200 · DOI · Paper page
  21. 10.1016/j.cub.2013.02.033 · DOI
  22. L Chen, , Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest 119, 3257–3265 (2009).
  23. 10.1016/j.nbd.2013.12.011 · DOI
  24. 10.1016/j.expneurol.2005.04.011 · DOI
  25. 10.1038/ncomms5763 · DOI
  26. 10.1016/j.chembiol.2013.10.012 · DOI
  27. 10.1091/mbc.10.8.2583 · DOI
  28. 10.1128/MCB.21.14.4482-4494.2001 · DOI
  29. 10.1074/jbc.M113.529461 · DOI
  30. 10.1093/jb/mvu069 · DOI
  31. 10.1523/JNEUROSCI.2898-12.2013 · DOI
  32. 10.1371/journal.pone.0029460 · DOI
  33. 10.1016/j.mcn.2015.02.009 · DOI
  34. 10.1021/pr300536k · DOI
  35. 10.1016/j.cell.2014.05.048 · DOI · Paper page
  36. 10.1002/mds.25136 · DOI
  37. 10.1016/j.brainres.2007.12.014 · DOI · Paper page
  38. 10.1038/cddis.2013.546 · DOI
  39. 10.1371/journal.pone.0087388 · DOI
  40. 10.1152/ajpcell.00462.2010 · DOI

Cited by

Sorted by citations

Metadata

Authors
Alexopoulou, Z., Lang, J., Perrett, R. M., Elschami, M., Hurry, M. E. D., Kim, H. T., Mazaraki, D., Szabo, A., Kessler, B. M., Goldberg, A. L., Ansorge, O., Fulga, T. A., & Tofaris, G. K.
Affiliations
  • Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom;
  • Department of Cell Biology, Harvard Medical School, Boston, MA 02115;
  • Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom;
  • Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom
Venue
Proceedings of the National Academy of Sciences
Published
2016-07-21
Volume
113
Issue
32
ISSN
  • 0027-8424
  • 1091-6490
Cited by
125
References
5
Language
en
Funders
  • Wellcome Trust (97479/Z/11/X)
  • Oxford Biomedical Research Centre (N/A)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review